Effects of angiotensin II type I receptor antagonist and Ca antagonist on blood pressure in relation to pre-treatment plasma renin or plasma aldosterone levels

被引：0
|
作者：
Izumi, Y. [1 ]
Matsumoto, K. [1 ]
Kasamaki, Y. [2 ]
Shindo, A. [2 ]
Ohta, M. [2 ]
Hirayama, A. [2 ]
Ozawa, Y. [2 ]
Nakayama, T. [3 ]
机构：
[1] Nihon Univ, Sch Med, Dept Med, Div Nephrol & Endocrinol, Tokyo, Japan
[2] Nihon Univ, Sch Med, Dept Med, Div Cardiol, Tokyo, Japan
[3] Nihon Univ, Sch Med, Dept Adv Med Sci, Div Mol Diagnost, Tokyo, Japan
来源：
JOURNAL OF HYPERTENSION | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S520 / S520
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF ANGIOTENSIN-II AND ANTAGONIST ANALOGS ON PLASMA ALDOSTERONE IN DOGS
    GYSLING, E
    LEHOUX, JG
    PARK, WK
    REGOLI, D
    CIRCULATION, 1974, 50 (04) : 178 - 178
  • [2] Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: Relation to the renin-aldosterone system
    Resnick, LM
    Catanzaro, D
    Sealey, JE
    Laragh, JH
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (03) : 203 - 208
  • [3] Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system
    Resnick, L. M.
    Catanzaro, D.
    Sealey, J. E.
    Laragh, J. H.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (06): : 35 - 41
  • [4] Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin aldosterone system in hypertensive patients
    Ichikawa, S
    Takayama, Y
    HYPERTENSION RESEARCH, 2001, 24 (06) : 641 - 646
  • [5] Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients
    Ichikawa, Shuichi
    Takayama, Yoshiaki
    RUSSIAN JOURNAL OF CARDIOLOGY, 2011, (03): : 33 - 39
  • [6] EFFECTS OF SARALASIN, AN ANGIOTENSIN-II ANTAGONIST, ON BLOOD-PRESSURE AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN NORMAL AND HYPERTENSIVE SUBJECTS
    BROWN, JJ
    BROWN, WCB
    FRASER, R
    LEVER, AF
    MORTON, JJ
    ROBERTSON, JIS
    ROSEI, EA
    TRUST, PM
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1976, 6 : 48 - 52
  • [7] Effects of angiotensin II receptor antagonist losartan on microalbuminuria and blood pressure in type II diabetic patients
    Ragonesi, PD
    Belviso, A
    Taddei, MT
    JOURNAL OF HYPERTENSION, 1998, 16 : S166 - S166
  • [8] EFFECTS OF ANGIOTENSIN-II ON BLOOD-PRESSURE, PLASMA-RENIN ACTIVITY, AND ALDOSTERONE IN THE FETAL LAMB
    SIEGEL, SR
    OAKS, G
    PALMER, S
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1981, 3 (03): : 144 - 149
  • [9] Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II Type 1 receptor antagonist and their plasma levels in patients with chronic renal failure
    Shibasaki, Y
    Mori, Y
    Tsutumi, Y
    Masaki, H
    Sakamoto, K
    Murasawa, S
    Maruyama, K
    Moriguchi, Y
    Tanaka, Y
    Iwasaka, T
    Inada, M
    Matsubara, H
    CLINICAL NEPHROLOGY, 1999, 51 (02) : 83 - 91
  • [10] BIOCHEMICAL EFFECTS OF LOSARTAN, A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
    GOLDBERG, MR
    BRADSTREET, TE
    MCWILLIAMS, EJ
    TANAKA, WK
    LIPERT, S
    BJORNSSON, TD
    WALDMAN, SA
    OSBORNE, B
    PIVADORI, L
    LEWIS, G
    BLUM, R
    HERMAN, T
    ABRAHAM, PA
    HALSTENSON, CN
    LO, MW
    LU, H
    SPECTOR, R
    HYPERTENSION, 1995, 25 (01) : 37 - 46
12345